VT News
James Storm

James Storm

Ask VT AI
View News Summary
  • Fed cuts rates, but December QT uncertain as markets parse mixed signals from policymakers.
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Trump boasts of acing cognitive test, challenges Crockett and AOC to take it, as scrutiny over his health continues.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Fed cuts rates, but December QT uncertain as markets parse mixed signals from policymakers.
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Trump boasts of acing cognitive test, challenges Crockett and AOC to take it, as scrutiny over his health continues.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from James Storm

Top Topics

Trending in U.S.

World

Sport